ARCHIVES

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

This article is from The Cancer Letter archive.

Vol. 22 No. 48 | December 13, 1996

Download PDF Visit The Full Archive

Related Articles

ACS Board Ok’s $93 Mil. Research Grants Budget, Society’s Largest Ever

March 27, 1992

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

NIH Reauthorization Still Lingering, Bills ‘Tie Hands’ Of NCI Director

October 18, 1991

House Passes Cancer Bill With Mandates for NCI

September 28, 2012

In Brief: Broder Keynote Speaker At ACCC Meeting; Tefft To Head Radiation Therapy At Cleveland Clinic

February 24, 1989